Health-care companies rose, but not by as much as the broad market, amid mixed earnings reports.
Shares of drug-store chain and insurer CVS Health fell after it cut growth estimates for the third consecutive quarter.
IQVIA Holdings shares slipped after the provider of services to life-sciences companies cut its 2023 revenue target, as it anticipated a strong rate of sales growth to falter somewhat at the year's end.
Aldeyra Therapeutics shares surged after drug giant AbbVie secured an option to license an eye-condition drug from the development-stage biotech company.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
11-01-23 1801ET
